Log in
Local authorities, the UK government and the European Commission have benefitted from the widespread application of new molecular methodologies, developed in 2005 and applied by the University of Reading's Vertebrate Pests Unit (VPU) to identify and quantify anticoagulant rodenticide resistance in rodent populations. Rodents are a major global pest that consumes our food, causes contamination with urine and faeces, damages structures through gnawing, transmits diseases, and impacts on species of conservation concern. Due to historical success and recent regulatory restrictions, anticoagulant rodenticides are the most common control method for these pests. However, physiological resistance to anticoagulants is now widespread and the VPU has been involved in mapping this resistance and identifying the genetic basis for the resistance. Their research has led to new methodologies to identify anticoagulant resistance that have been adopted by the global plant science industry and to new guidance in treating resistant populations that has been adopted by the European biocides industry.
Development of the human cell GADD45a assay enabled accurate identification of carcinogens in vitro, with a low rate of misleading positives. Through the spin-out company Gentronix, this research is reducing costs to industry and decreasing the use of animals in research. Industrial collaboration has enabled commercial adoption of the technology in many sectors. With a 10-fold increase in orders in 2012 versus 2008, Gentronix is a profitable business employing 17 people and with an annual turnover of £1.88m. During 2008-12, Gentronix released a series of new products, established testing services, and signed a product license agreement with GlaxoSmithKline. More than 100 companies worldwide are using Gentronix kits, including pharmaceutical, agricultural and health and beauty companies, along with manufacturers of food flavourings and household goods. The Gentronix assay is currently being reviewed by the European Centre for the Validation of Alternative Methods.
Series of images from animal behaviour studies contain vast quantities of complex and highly valuable data. Extracting the value from this scientific data often requires expert annotation. This is frequently an intuitive process based on experience gained through years of training to make important decisions. Experts are rare, expensive and hard to train so the iBehave project at the University of Edinburgh (2006-2009) sought to reverse this model and deliver systems that learned to mimic expert annotation of video data. This effort resulted in a new spinout from the School of Informatics, a software company called Actual Analytics Ltd (Actual). Founded in 2010, Actual delivers innovative software solutions for behaviour analytics which use machine learning algorithms to process video data of laboratory animals to improve the accuracy of the experimental process and reduce the need to use animals in scientific research.
African Wild Dogs (Lycaon pictus; referred to as `AWDs' hereafter for brevity) have been classed as endangered by the International Union for Conservation of Nature (IUCN) for 22 years. Large, well-managed captive breeding programmes provide a safety net to restore wild populations. However, the management of the AWD population has been difficult owing to an incomplete family record of captive AWDs, which risks introducing genetic disorders caused by inbreeding. A genetically informed management plan developed by University of Glasgow researchers has provided a genetic measure of diversity and establishes a genetically informed pedigree, which is used in the European Endangered Species Programme for African Wild Dogs. This has introduced a more informed means to manage the captive AWD population, to maintain the genetic diversity of the species across the European zoo network (roughly half the world's captive AWD population), with 53 zoos in 16 European countries (and Israel) currently participating.
Research on clinically important red blood cell membrane proteins has helped avoid unnecessary treatment of Rhesus negative pregnant women and enabled the early diagnosis of a rare kidney disease. During the late 1990s, researchers at the University of Bristol, in collaboration with the Blood Service in Bristol, cloned, sequenced and characterised many red blood cell membrane proteins important for transfusion, including the Rhesus proteins and Band 3/AE1 (SLC4AE1 gene). The work on Rhesus proteins facilitated the use of less invasive genetic screening methods to ascertain whether treatment was required to avoid Haemolytic Disease of the Foetus or Newborn (HDFN). In the UK, 5,000 women have been screened since 2001. Within the first six months of implementation of a Danish national screening program in January 2010, 862 women avoided unnecessary treatment. Reducing unnecessary treatment of mothers has saved resources and avoided unnecessary exposure to human derived blood products. In addition, research that has identified specific SLC4AE1 gene mutations that cause the rare kidney disease called distal renal tubular acidosis has enabled the early diagnosis and treatment of the disease, resulting in improved outcomes for patients.
In High Gravity (HG) brewing the substrate (the wort§) fermented by the yeast is concentrated from a traditional value of about 12% solids to concentrations of upwards of 20%. Research (1993-2008) by Graham's Stewart's team at Heriot-Watt, into the process of brewing beer and distilling spirits in a more cost effective and quality enhanced manner led to substantial improvements in the HG brewing process, now used worldwide. This allows up to 50% more beer to be made at the same plant and reduces distillation costs. In both industries HG-wort production has allowed very substantial savings (>£555 million) in capital expansion costs.
§The substrate produced by the mashing of malt and grains — primarily consisting of fermentable sugars.
Research and knowledge dissemination led by Greenwich on biological pesticides has made a major contribution to the introduction of novel safe commercial pesticides based on insect viruses to help farmers overcome the problems of chemical resistance in major crop pests in Asia and Africa. Research at Greenwich identified effective virus strains, methods of production and formulation which were then developed and evaluated with in country research collaborators before being transferred to local SMEs to start up production in India, Thailand, Kenya and Tanzania. Greenwich advised governments on adopting suitable regulation to support the registration and sale of these novel pesticides.
The zebra mussel is one of the world's most economically and ecologically important pests, but existing control approaches cause significant deleterious environmental effects. Researchers at the University of Cambridge have developed a `BioBullet' against zebra mussels, which encapsulates toxins in a harmless edible coat, enabling efficient, targeted product delivery and dramatically reducing environmental pollution. [text removed for publication] Further successful formulations are being developed by the researchers and the company for fouling in shrimp farms and enhancing shellfish aquaculture.
The zebra mussel is one of the world's most damaging invasive species, but existing control approaches cause significant environmental damage. Researchers at the University of Cambridge have developed the patented `BioBullet', which encapsulates a toxic active ingredient in a harmless edible coating, enabling efficient, targeted product delivery and dramatically reducing environmental pollution. [text removed for publication]
Researchers at the University of Leeds (UoL) have identified mutations in key genes which are major causes of deafness and blindness. Mutations in GJB2, identified in a Leeds/London collaboration, are the most common cause of human inherited deafness, affecting millions worldwide, and Leeds researchers have also highlighted 13 key genes involved in inherited blindness, accounting for an estimated 5% of around 2 million people throughout the world with inherited eye diseases. This work has led to the availability of vital genetic testing, enabling early diagnosis, better management and improving outcomes for patients, as well as better counselling and prenatal screening for families.